Latest Headlines
The Future Of Wound Care With Ajisafe Taiye Abdulafeez
Salami Adeyinka
Wound care sits at a quiet crossroads in medicine. While new technologies and biologics make headlines, the daily reality in many hospitals is still gauze, iodine, and time. The gap between what’s possible and what’s accessible costs limbs, lives, and livelihoods. Ajisafe Taiye Abdulafeez works inside that gap.
As a medical officer in surgery, his view of wounds is unsentimental. Burns, trauma, surgical site infections, necrotizing fasciitis , he sees them early and he sees them late. “A wound is a story,” he says.
“It tells you where the patient has been, what the system missed, and how much time you have left to act.” That story shapes how he thinks about the future of wound care: it must be faster, cheaper, and closer to the patient.
His approach starts with observation. Bedside rounds double as data collection. Why did this typhoid perforation present with established sepsis? Which referral broke down? Why did this diabetic foot ulcer advance to necrosis before debridement? To Ajisafe, the future of wound care isn’t just new dressings. It’s new pathways, shorten pre-hospital delays, tighten triage, and half your complications disappear before the first scalpel touches skin.
But he’s equally focused on the wound itself. His current research asks hard, practical questions: Can papain enzyme from pawpaw leaves deliver safe, low-cost enzymatic debridement where surgical capacity is limited? How do we standardize it? What does effective, dignified wound management look like when power, water, or theater time isn’t guaranteed? “Innovation here can’t wait for perfect conditions,” he argues. “If it doesn’t work with what we have today, it isn’t innovation it’s inventory.”
Training is the other lever he pulls. As Acting Chief Registrar and Deputy Chief Registrar, he runs case discussions and supervises house officers on the simple truth that most wounds are lost or saved before the consultant arrives. He teaches junior doctors to read tissue the way others read vitals: color, edge, exudate, odor, pain. “If we teach wound care as an afterthought, we will bury patients in preventable sepsis,” he warns. “It has to be core curriculum, not cleanup.”
For Ajisafe, the future of wound care rests on three pillars:
Access: Local solutions for debridement, irrigation, and dressing that don’t depend on fragile supply chains.
Evidence: Bedside-to-bench studies that test what actually works in high-volume, low-resource theatres.
Education: A generation of clinicians who treat wound assessment with the same urgency as airway, breathing, and circulation.
He is not romantic about technology. Negative pressure systems and bioengineered grafts have their place. But the next decade of lives saved will come from systems thinking: referral maps that work, community health education that sends patients in earlier, and protocols that let a medical officer in Azare achieve the same baseline outcome as a specialist anywhere else.
“The future of wound care,” Ajisafe says, “is not a product launch. It’s a patient who gets to us two days earlier, a nurse who knows exactly when to escalate, and a junior doctor who can debride safely at 2 a.m. without waiting for daylight.”
That future is built on ledgers, not logos, careful records of what failed, what worked, and what can be taught by morning.







